You need flash player 7 or above to view this content. Please update at the link below.
Dr. Lauren Shatz offers some pearls for transitioning to EMR in ophthalmic practice. Dr. Shatz discusses choosing EMR, nuances of EMR modules, as well as the initial time investment that it takes to implement EMR. Dr. Shatz also touches on the efficiencies that are the payoff for transitioning to EMR.
more
Japan's leading ophthalmic pharmaceutical company, announced today that Adrienne L. Graves, PhD, President and Chief Executive Officer (CEO) of its wholly-owned U.S. subsidiary, Santen Inc. (Napa, CA), has resigned and will continue to work with Santen as a strategic consultant and advisor to the Senior Management of Santen.
Source: Santen Ltd
VANCOUVER, British Columbia, March 10, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced results from Phase II clinical trials and a device study for the punctal plug delivery system (PPDS). These studies are part of a development program that is being conducted by QLT's wholly-owned subsidiary, QLT Plug Delivery, Inc. QLT also announced its plans to expand the program to evaluate a second drug for a new target indication.
Source: GLOBE NEWSWIRE
More News Articles
Vendors, get information about advertising, sponsorship opportunities, multimedia production, and listing your products on OphthalmologyWeb.
Learn more about advertising
Sponsored by
The following is a slit lamp photograph of a 60 year old woman with complaints of chronic foreign body sensation. Which of the following is the least likely cause of her condition?
You do not have JavaScript enabled or are using an older version of Adobe Flash. You can update your version of Adobe Flash here.
Apr 09 - Apr 14, 2010
Boston, MA
More Information
More Events
OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.
Learn more about writing